DJ Catalyst Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Catalyst Pharmaceuticals Inc. $(CPRX)$ slid 3.26% to $21.35 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 3.56% to 19,392.69 and Dow Jones Industrial Average falling 2.58% to 42,326.87.
The stock's fall snapped a three-day winning streak.
Catalyst Pharmaceuticals Inc. closed $2.92 short of its 52-week high ($24.27), which the company achieved on November 8th.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ fell 1.13% to $144.75, Pfizer Inc. $(PFE)$ fell 2.04% to $25.89, and Abbott Laboratories $(ABT)$ fell 1.20% to $111.93.
Trading volume (1.2 M) eclipsed its 50-day average volume of 926,070.
Data source: Dow Jones Market Data, FactSet. Data compiled December 18, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
December 18, 2024 17:22 ET (22:22 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments